Bio-Path announces $1.2M registered direct offering priced at-the-market

Like
Comment
Favorite

Bio-Path announces $1.2M registered direct offering priced at-the-market

seekingalpha04-19

Bio-Path (NASDAQ:BPTH) on Thursday announced that it entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares at $3.225/share in a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2428453595?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-19 02:28","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2428453595","market":"nz","top_or_hot":-1,"title":"Bio-Path announces $1.2M registered direct offering priced at-the-market","media":"seekingalpha","content":"<div>\n<p>Bio-Path (NASDAQ:BPTH) on Thursday announced that it entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares at $3.225/share in a ...</p>\n\n<a href=\"https://seekingalpha.com/news/4091186-bio-path-announces-12m-registered-direct-offering-priced-at-the-market\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Path announces $1.2M registered direct offering priced at-the-market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Path announces $1.2M registered direct offering priced at-the-market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-19 02:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4091186-bio-path-announces-12m-registered-direct-offering-priced-at-the-market><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bio-Path (NASDAQ:BPTH) on Thursday announced that it entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares at $3.225/share in a ...</p>\n\n<a href=\"https://seekingalpha.com/news/4091186-bio-path-announces-12m-registered-direct-offering-priced-at-the-market\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/4091186-bio-path-announces-12m-registered-direct-offering-priced-at-the-market","article_id":"2428453595","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428453595","pubTimestamp":1713464915,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Bio-Path  on Thursday announced that it entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares at $3.225/share in a registered direct offering priced at-the-market. Additionally, in a concurrent private placement, Bio-Path also agreed to issue to such investors unregistered warrants to purchase up to 375,000 shares at an exercise price of $3.10 per share.  The gross proceeds from the offering are expected to be about $1.2 million, which Bio-Path intends to use towards working capital and general corporate purposes. Source: Press Release    More on Bio-Path  Bio-Path Holdings Inc.  Q4 2023 Earnings Call Transcript Bio-Path shares rally after clinical trial progress of BP1002 Seeking Alpha’s Quant Rating on Bio-Path Historical earnings data for Bio-Path Financial information for Bio-Path","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BPTH":"Bio-Path Holdings, Inc."},"translate_title":"Bio-Path宣布120万美元注册直接发行，按市价定价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BPTH":1},"content_text":"Bio-Path (NASDAQ:BPTH) on Thursday announced that it entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares at $3.225/share in a registered direct offering priced at-the-market. Additionally, in a concurrent private placement, Bio-Path also agreed to issue to such investors unregistered warrants to purchase up to 375,000 shares at an exercise price of $3.10 per share.  The gross proceeds from the offering are expected to be about $1.2 million, which Bio-Path intends to use towards working capital and general corporate purposes. Source: Press Release    More on Bio-Path  Bio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcript Bio-Path shares rally after clinical trial progress of BP1002 Seeking Alpha’s Quant Rating on Bio-Path Historical earnings data for Bio-Path Financial information for Bio-Path","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}